Diseases requiring vitrectomy
Conditions
Interventions
Experimental group:Vitrectomy
Sponsors
Fudan University Affiliated Eye, Ear, Nose and Throat Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Patients planning to undergo vitrectomy 2. Patient age:>= 18 years 3. General condition meets surgical requirements 4. Voluntarily participate in this clinical trial and sign the subject's informed consent form 5. Patients meeting stage V DR criteria according to "China's Clinical Diagnosis and Treatment Guidelines for Diabetic Retinopathy (2022)"
Exclusion criteria
Exclusion criteria: 1. Patients with a history of ophthalmic surgery 2. Severe cardiopulmonary insufficiency or coagulation disorders 3. History of ocular infection within three months prior to screening, history of glaucoma, monocular patients, or equivalent spherical refractive error <= -6.00 D 4. Patients with retinopathy in both eyes requiring simultaneous vitrectomy treatment 5. Pregnant and lactating women, or those planning to become pregnant during the study period 6. Patients who are difficult to cooperate with 7. Other patients considered by the investigator to be unsuitable for participation in the clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgery success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total surgical time; Phacoemulsification time (if applicable); Core vitrectomy time;Membrane peeling time (if applicable); Intraoperative IOP;BCVA(logMAR);Retinal reattachment rate (if applicable); | — |
Countries
China
Contacts
Public ContactXu Gezhi
Fudan University Affiliated Eye, Ear, Nose and Throat Hospital
Outcome results
None listed